| Name: | Apremilast Impurity 2 |
| Catalogue No. | VE008008 |
| CAS No. | 6296-53-3 |
| Molecular Formula | C10H7NO4 |
| Molecular Weight | 205.2 g/mol |
| Status | In-Stock |
| IUPAC Name | N-(1,3-dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide |
| Synonyms | 3-Acetamidophthalic anhydride |
| Description | Apremilast Impurity 2 (CAS NO.-6296-53-3) IUPAC Name-N-(1,3-dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide. Apremilast is an oral phosphodiesterase 4 inhibitor that has an impact on a wide range of inflammatory mediators involved in psoriasis and psoriatic arthritis, this is the novel treatment that focuses on maintaining a balance between pro-inflammatory and anti-inflammatory signals. |
| References | Schafer, Peter. “Apremilast Mechanism of Action and Application to Psoriasis and Psoriatic Arthritis.” Biochemical Pharmacology, vol. 83, no. 12, June 2012, pp. 1583–90, https://doi.org/10.1016/j.bcp.2012.01.001. |
